These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 27165819)

  • 1. Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease.
    Carrillo-López N; Panizo S; Alonso-Montes C; Román-García P; Rodríguez I; Martínez-Salgado C; Dusso AS; Naves M; Cannata-Andía JB
    Kidney Int; 2016 Jul; 90(1):77-89. PubMed ID: 27165819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation both increases and causes resistance to FGF23 in normal and uremic rats.
    Rodríguez-Ortiz ME; Díaz-Tocados JM; Muñoz-Castañeda JR; Herencia C; Pineda C; Martínez-Moreno JM; Montes de Oca A; López-Baltanás R; Alcalá-Díaz J; Ortiz A; Aguilera-Tejero E; Felsenfeld A; Rodríguez M; Almadén Y
    Clin Sci (Lond); 2020 Jan; 134(1):15-32. PubMed ID: 31860056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of renal Klotho and FGFR1 in normal and uremic rats.
    Muñoz-Castañeda JR; Herencia C; Pendón-Ruiz de Mier MV; Rodriguez-Ortiz ME; Diaz-Tocados JM; Vergara N; Martínez-Moreno JM; Salmerón MD; Richards WG; Felsenfeld A; Kuro-O M; Almadén Y; Rodríguez M
    FASEB J; 2017 Sep; 31(9):3858-3867. PubMed ID: 28515153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The suppressive effect of soluble Klotho on fibroblastic growth factor 23 synthesis in UMR-106 osteoblast-like cells.
    Ma L; Gao M; Wu L; Zhao X; Mao H; Xing C
    Cell Biol Int; 2018 Sep; 42(9):1270-1274. PubMed ID: 29851201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 23 (FGF23) and alpha-klotho stimulate osteoblastic MC3T3.E1 cell proliferation and inhibit mineralization.
    Shalhoub V; Ward SC; Sun B; Stevens J; Renshaw L; Hawkins N; Richards WG
    Calcif Tissue Int; 2011 Aug; 89(2):140-50. PubMed ID: 21633782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant FGF23 prevents the progression of chronic kidney disease but aggravates renal osteodystrophy in uremic rats.
    Kusano K; Saito H; Segawa H; Fukushima N; Miyamoto K
    J Nutr Sci Vitaminol (Tokyo); 2009 Apr; 55(2):99-105. PubMed ID: 19436134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of Wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation.
    Hie M; Iitsuka N; Otsuka T; Tsukamoto I
    Int J Mol Med; 2011 Sep; 28(3):455-62. PubMed ID: 21567076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease.
    Carrillo-López N; Panizo S; Alonso-Montes C; Martínez-Arias L; Avello N; Sosa P; Dusso AS; Cannata-Andía JB; Naves-Díaz M
    Nephrol Dial Transplant; 2019 Jun; 34(6):934-941. PubMed ID: 30189026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying early pathogenic events during vascular calcification in uremic rats.
    Hortells L; Sosa C; Guillén N; Lucea S; Millán Á; Sorribas V
    Kidney Int; 2017 Dec; 92(6):1384-1394. PubMed ID: 28844316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency.
    Jimbo R; Kawakami-Mori F; Mu S; Hirohama D; Majtan B; Shimizu Y; Yatomi Y; Fukumoto S; Fujita T; Shimosawa T
    Kidney Int; 2014 May; 85(5):1103-11. PubMed ID: 24088960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Klotho/FGF23 axis mediates high phosphate-induced vascular calcification in vascular smooth muscle cells via Wnt7b/β-catenin pathway.
    Chen YX; Huang C; Duan ZB; Xu CY; Chen Y
    Kaohsiung J Med Sci; 2019 Jul; 35(7):393-400. PubMed ID: 31001900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High calcium, phosphate and calcitriol supplementation leads to an osteocyte-like phenotype in calcified vessels and bone mineralisation defect in uremic rats.
    Bisson SK; Ung RV; Picard S; Valade D; Agharazii M; Larivière R; Mac-Way F
    J Bone Miner Metab; 2019 Mar; 37(2):212-223. PubMed ID: 29603070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
    Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
    Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease.
    Muñoz-Castañeda JR; Rodelo-Haad C; Pendon-Ruiz de Mier MV; Martin-Malo A; Santamaria R; Rodriguez M
    Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32188018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats.
    Román-García P; Carrillo-López N; Naves-Díaz M; Rodríguez I; Ortiz A; Cannata-Andía JB
    Endocrinology; 2012 Apr; 153(4):1627-37. PubMed ID: 22334717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased parathyroid expression of klotho in uremic rats.
    Hofman-Bang J; Martuseviciene G; Santini MA; Olgaard K; Lewin E
    Kidney Int; 2010 Dec; 78(11):1119-27. PubMed ID: 20631679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fgf23 and parathyroid hormone signaling interact in kidney and bone.
    Andrukhova O; Streicher C; Zeitz U; Erben RG
    Mol Cell Endocrinol; 2016 Nov; 436():224-39. PubMed ID: 27498418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.
    Finch JL; Tokumoto M; Nakamura H; Yao W; Shahnazari M; Lane N; Slatopolsky E
    Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1315-22. PubMed ID: 20200094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Klotho expression in long bones regulates FGF23 production during renal failure.
    Kaludjerovic J; Komaba H; Sato T; Erben RG; Baron R; Olauson H; Larsson TE; Lanske B
    FASEB J; 2017 May; 31(5):2050-2064. PubMed ID: 28183805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.
    Lavi-Moshayoff V; Wasserman G; Meir T; Silver J; Naveh-Many T
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F882-9. PubMed ID: 20685823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.